Adjuvant induced glucose uptake by activated T cells is not correlated with increased survival

Advances in Experimental Medicine and Biology

Volumn 614, Issue , 2008, Pages 65-72

  Sengupta, Sadhak ^a   Vitale, Rebecca J ^a   Chilton, Paula M ^a   Mitchell, Thomas C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NBDG; BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHALASIN B; DEOXYGLUCOSE; PHLORETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE TRANSPORT; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); MUS;

EID: 84934442495     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74911-2_8     Document Type: Conference Paper

References (18)

1. A.T. Vella, J.E. McCormack, P.S. Linsley, J.W. Kappler, and P. Marrack. "Lipopolysaccharide interferes with the induction of peripheral T cell death." Immunity 2, no. 3(March 1995):261-70.
2. T. Mitchell, J. Kappler, and P. Marrack. "Bystander virus infection prolongs activated T cell survival." J. Immunol. 162, no. 8 (April 1999):4527-35.
3. T.C. Mitchell, T.K. Teague, D.A. Hildeman, J. Bender, W.A. Rees, R.M. Kedl, B. Swanson, J.W. Kappler, and P. Marrack. "Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survival." Ann. N. Y. Acad. Sci. 975, (December 2002):114-31.
4. L.P. Kane and A. Weiss. "The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3." Immunol. Rev. 192, (April 2003):7-20.
5. F.V. Lali, J. Crawley, D.A. McCulloch, and B.M. Foxwell. "A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation." J. Immunol. 172, no. 6 (March 2004):3527-34.
6. S. Sengupta, P.M. Chilton, and T.C. Mitchell. "Adjuvant-induced survival signaling in clonally expanded T cells is associated with transient increases in pAkt levels and sustained uptake of glucose." Immunobiology 210, no. 9 (2005):647-59.
7. J.C. Rathmell, C.J. Fox, D.R. Plas, P.S. Hammerman, R.M. Cinalli, and C.B. Thompson. "Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival." Mol. Cell Biol. 23, no. 20 (October 2003):7315-28.
8. C.A. Doughty, B.F. Bleiman, D.J. Wagner, F.J. Dufort, J.M. Mataraza, M.F. Roberts, and T.C. Chiles. "Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth." Blood 107, no. 11 (June 2006):4458-65.
9. K.A. Frauwirth and C.B. Thompson. "Regulation of T lymphocyte metabolism." J. Immunol. 172, no. 8 (April 2004):4661-65.
10. B. Hellwig and H.G. Joost. "Differentiation of erythrocyte-(GLUT1), liver-(GLUT2), and adipocyte-type (GLUT4) glucose transporters by binding of the inhibitory ligands cytochalasin B, forskolin, dipyridamole, and isobutylmethylxanthine." Mol. Pharmacol. 40, no. 3 (September 1991):383-89.
11. M. Kobori, H. Shinmoto, T. Tsushida, and K. Shinohara. "Phloretin-induced apoptosis in B16 melanoma 4A5 cells by inhibition of glucose transmembrane transport." Cancer Lett 119, no. 2 (November 1997):207-12.
12. J.E. McCormack, J.E. Callahan, J. Kappler, and P.C. Marrack. "Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen." J. Immunol. 150, no. 9 (May 1993):3785-92.
13. A. Virkamaki, E. Rissanen, S. Hamalainen, T. Utriainen, and H. Yki-Jarvinen. "Incorporation of [3-3H]glucose and 2-[1-14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo: implications for the quantitation of tissue glucose uptake." Diabetes 46, no. 7 (July 1997):1106-10.
14. K. Yoshioka, H. Takahashi, T. Homma, M. Saito, K.B. Oh, Y. Nemoto, and H. Matsuoka. "A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli." Biochim. Biophys Acta 1289, no. 1 (February 1996):5-9.
15. A. Ghosh, J. Maniloff, and D.A. Gerling. "Inhibition of mycoplasma cell division by cytochalasin B." Cell 13, no. 1 (January 1978):57-64.
16. P.A. Theodoropoulos, A. Gravanis, A. Tsapara, A.N. Margioris, E. Papadogiorgaki, V. Galanopoulos, and C. Stournaras. "Cytochalasin B may shorten actin filaments by a mechanism independent of barbed end capping." Biochem Pharmacol. 47, no. 10 (May 1994):1875-81.
17. J.F. Griffin, A.L. Rampal, and C.Y. Jung. "Inhibition of glucose transport in human erythrocytes by cytochalasins: A model based on diffraction studies." Proc. Natl. Acad. Sci. U. S. A. 79, no. 12 (June 1982):3759-63.
18. R.M. Krupka. "Asymmetrical binding of phloretin to the glucose transport system of human erythrocytes." J. Membr. Biol. 83, no. 1-2 (1985):71-80.